Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

Program turns Tucson police into 'street-corner problem solvers' From the Arizona Daily Star reporter Jamie Donnelly's top stories of 2022 series ...

Student Loan Repayments Are About to Look Very Different By next summer, new borrowers will have just two repayment options, streamlining the previous menu to pay off higher-education debt. Here ...